v3.25.2
Collaborations and Other Arrangements - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Mar. 31, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Revenue $ 15,557.7 $ 11,302.8 $ 28,286.2 $ 20,070.8  
Jardiance          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Revenue 690.0 $ 769.6 1,704.3 $ 1,456.1  
Jardiance | One Time Payment          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Revenue     370.0    
Boehringer Ingelheim | Milestone Payments, Sales-based          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Potential achievements         $ 610.0
Ebglyss | Milestone Payments, Sales-based          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Potential achievements 1,250.0   1,250.0    
Ebglyss | Milestone Payments, Sales-based | Roche          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Potential achievements 1,030.0   1,030.0    
Orforglipron | Milestone Payments, Sales-based | Chugai          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Potential achievements 250.0   250.0    
Orforglipron | Milestone Payments, Development and Regulatory | Chugai          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Potential achievements $ 140.0   $ 140.0